What would you like to find?
Fax (913) 361-0000
7381 West 133rd Street, Suite 401, Overland Park, KS 66213
Board-Certified Psychiatrist

IV Ketamine for PTSD in Kansas City: An Off-Label, Glutamate-Based Approach

middle aged couple walking along dirt road peacefully at sunset after trying ketamine for ptsd in kansas city

Understanding IV Ketamine for PTSD

Post-traumatic stress disorder affects millions of Americans each year. Trauma-focused psychotherapy is a central part of evidence-based PTSD care, and medication may also be part of treatment. Still, some people continue to experience intrusive memories, hyperarousal, avoidance, and emotional distress despite previous care.

Research has increasingly explored the role of the glutamate system in PTSD and the potential role of ketamine, a medication that affects NMDA receptors. At our Kansas City clinic, we offer IV ketamine treatment as an off-label option for patients with PTSD after an individualized psychiatric evaluation.

We are also direct about the limits of the evidence. IV ketamine is not FDA-approved for PTSD, and current VA/DoD guidance does not recommend it as a standard PTSD treatment. Research is ongoing, and treatment decisions should consider the potential benefits, limitations, risks, and alternatives for each patient.

PTSD, Trauma, and the Glutamate System

PTSD is not simply an emotional response to a difficult experience. It is associated with changes in brain systems involved in threat detection, memory, emotional regulation, and stress response.

Research has described differences in the activity and connectivity of regions involved in these processes, including the amygdala and prefrontal cortex. Glutamate, the brain’s primary excitatory neurotransmitter, is involved in these systems and in synaptic plasticity.

Ketamine primarily acts as an NMDA receptor antagonist. Researchers are studying how its effects on glutamate signaling may influence neural circuits involved in mood, fear learning, and trauma-related symptoms. The precise mechanism of ketamine in PTSD is still being investigated.

For a broader overview of how ketamine interacts with the brain, read our post on how ketamine may affect mental health.

What the Research Shows

The clinical evidence for ketamine in PTSD is still developing. Early randomized trials found that some adults with chronic PTSD experienced rapid reductions in symptom severity after IV ketamine compared with an active control. A later trial of repeated infusions also reported symptom improvement for some participants.

At the same time, the overall research base remains mixed, and clinical guidelines have concluded that the available evidence does not establish a clear enough benefit to recommend ketamine as a standard treatment for PTSD.

This means IV ketamine should not be viewed as a replacement for established trauma-focused psychotherapy or as a guaranteed solution. It is an off-label option that requires careful evaluation and clear expectations.

For a deeper look at how IV ketamine has been explored across different mental health conditions, see our post on IV ketamine for PTSD: a cutting-edge solution in Kansas City.

How IV Ketamine May Fit Into a PTSD Treatment Plan

We do not think of ketamine as a standalone solution for PTSD. When appropriate, it may be considered alongside an existing treatment plan rather than in place of trauma-focused psychotherapy, medication management, or other recommended care.

For some patients, symptoms such as hyperarousal, sleep disruption, intrusive thoughts, or emotional distress can make daily life and therapy more difficult. We discuss whether IV ketamine may fit into the broader clinical picture, including current treatment, prior treatment response, medical history, and personal goals.

Patients can also review our PTSD treatment information for more about the services available through our practice.

What to Expect During IV Ketamine Treatment

At our clinic, IV ketamine infusions are generally administered over approximately 40 minutes in a monitored setting. Patients are observed throughout treatment, and we discuss what they may experience before treatment begins.

Some patients experience temporary perceptual changes during an infusion, such as a dreamlike feeling, altered sense of time, or dissociation. For someone with PTSD, that possibility can feel concerning. We take these concerns seriously, review symptom history carefully, and create a calm, controlled environment.

Treatment plans are individualized. At our clinic, an initial series generally consists of six once-weekly infusions. This differs from compressed protocols that schedule several infusions over a shorter period. Learn more about what IV ketamine infusion therapy involves.

Cost and Access Considerations

Because IV ketamine for PTSD is an off-label psychiatric use, insurance coverage may be limited. Patients often pay out of pocket, and we discuss cost and practical considerations during the evaluation process.

Treatment also requires time and planning. We encourage patients to consider transportation, scheduling, support needs, and other logistical factors before beginning a course of treatment.

For more information about timing and scheduling, review our guide to how long ketamine infusion therapy may take.

Results and Candidacy

Results vary by individual. Some patients report symptom changes soon after treatment, while others experience more gradual or limited effects. Research has not established one predictable timeline, duration of benefit, or maintenance schedule for PTSD.

A thorough medical and psychiatric evaluation is important before treatment begins. Medical conditions, medications, substance-use history, psychiatric symptoms, and current treatment plans can all affect whether IV ketamine may be appropriate.

We are committed to honest conversations about what IV ketamine can and cannot offer. Our goal is to help patients make informed decisions, not to promise a particular outcome.

Frequently Asked Questions

Is IV ketamine for PTSD FDA-approved?
No. IV ketamine for PTSD is an off-label use. Ketamine has long been used in anesthesia, but it is not FDA-approved specifically for PTSD.

How does ketamine differ from SSRIs?
SSRIs primarily affect serotonin signaling. Ketamine primarily affects NMDA receptors and the glutamate system. The mechanisms differ, but that does not mean ketamine is a standard or universal replacement for medication-based PTSD care.

Can IV ketamine replace trauma-focused psychotherapy?
No. We do not present IV ketamine as a replacement for trauma-focused psychotherapy. When appropriate, it may be discussed as one part of a broader, individualized treatment plan.

Who may be a candidate for IV ketamine for PTSD?
Candidacy depends on your PTSD history, previous treatment, current symptoms, medical history, medications, and other clinical factors. A full psychiatric and medical evaluation is required before treatment is recommended.

How long do the effects of IV ketamine for PTSD last?
Response and duration of benefit vary. Research has not established one predictable timeline for PTSD. At our clinic, treatment plans are individualized, and any discussion of follow-up or maintenance care depends on a patient’s response and overall clinical picture.

Key Takeaways

  • IV ketamine for PTSD is an off-label use and is not FDA-approved specifically for PTSD.
  • Ketamine affects NMDA receptors and the glutamate system, though its precise role in PTSD treatment is still being studied.
  • Clinical trials have reported symptom improvement for some patients with chronic PTSD, but the evidence remains mixed.
  • Current VA/DoD guidance does not recommend ketamine as a standard PTSD treatment.
  • IV ketamine does not replace trauma-focused psychotherapy or individualized psychiatric care.
  • At our clinic, an initial IV ketamine course generally involves six once-weekly infusions, with treatment plans individualized to the patient.

Conclusion

PTSD can remain disruptive even after medication trials and therapy. Ketamine’s glutamate-based mechanism has generated clinical interest, but IV ketamine remains an off-label option for PTSD with an evolving evidence base.

At our Kansas City clinic, we approach PTSD treatment with careful evaluation, realistic expectations, and attention to the whole person. If you would like to discuss whether IV ketamine may fit your treatment history and goals, we invite you to request a consultation with Dr. Handoo’s team.

About Dr. Irfan Handoo

Irfan Handoo, MD, was born in Columbia, Maryland and grew up in Leawood, Kansas. He earned his undergraduate degree from UMKC and his Medical Doctorate at the UMKC School of Medicine in 2005.

Dr. Handoo completed his residency at the University of Kansas Medical Center at Wichita, where he completed a fellowship in psychopharmacology under the supervision of Dr. Sheldon Preskorn. He is board certified in psychiatry and is a Diplomate of the American Board of Psychiatry and Neurology.

Dr. Handoo is a member of the American Psychiatric Association, Clinical TMS Society, and American Society of Ketamine Physicians. He has been published in several journals, including The Journal of Child and Adolescent Psychopharmacology.

He is one of the most experienced psychiatrists in the country for treatment-resistant depression, was one of the first physicians to begin offering TMS in the Kansas City area, and was the first physician in the Kansas City area to begin IV ketamine treatment in 2016. He was among the first 300 physicians in the United States to begin offering IV ketamine treatment and has helped administer more than 8,000 IV ketamine treatments.

Dr. Handoo has been recognized as Expert Faculty by the American Society of Ketamine Physicians and has been selected as a Kansas City Top Doctor by Kansas City Magazine for 2022, 2023, 2024, 2025, and 2026.

Works Cited

Feder, A., Parides, M. K., Murrough, J. W., et al. (2014). Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: A randomized clinical trial. JAMA Psychiatry, 71(6), 681–688.

Feder, A., Costi, S., Rutter, S. B., et al. (2021). A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder. American Journal of Psychiatry, 178(2), 193–202.

National Institute of Mental Health. (n.d.). Post-traumatic stress disorder.

U.S. Department of Veterans Affairs, National Center for PTSD. (n.d.). Clinician’s guide to medications for PTSD.

Medical Disclaimer

The information provided in this blog is for educational purposes only and does not constitute medical advice. Treatment outcomes vary by individual. Results may vary. Please consult with a qualified healthcare provider before beginning any new treatment. Discuss with your provider whether this treatment is appropriate for you.

Request Your Consultation Today

Are you ready to get back to being the old you? Do you miss doing the things love the most with those you care about the most? Contact our experts today and learn how we can help you take back control of life.

CALL NOW
CONTACT US